- Home
- ATOS vs BLNK Comparison
ATOS vs BLNK Comparison
Compare ATOS & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- BLNK
- Stock Information
- Founded
- ATOS 2009
- BLNK 2009
- Country
- ATOS United States
- BLNK United States
- Employees
- ATOS N/A
- BLNK N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- BLNK Industrial Specialties
- Sector
- ATOS Health Care
- BLNK Consumer Discretionary
- Exchange
- ATOS Nasdaq
- BLNK Nasdaq
- Market Cap
- ATOS 96.8M
- BLNK 105.2M
- IPO Year
- ATOS 2012
- BLNK N/A
- Fundamental
- Price
- ATOS $0.74
- BLNK $0.71
- Analyst Decision
- ATOS Strong Buy
- BLNK Buy
- Analyst Count
- ATOS 3
- BLNK 8
- Target Price
- ATOS $7.13
- BLNK $3.19
- AVG Volume (30 Days)
- ATOS 714.9K
- BLNK 3.7M
- Earning Date
- ATOS 05-12-2025
- BLNK 05-08-2025
- Dividend Yield
- ATOS N/A
- BLNK N/A
- EPS Growth
- ATOS N/A
- BLNK N/A
- EPS
- ATOS N/A
- BLNK N/A
- Revenue
- ATOS N/A
- BLNK $126,197,000.00
- Revenue This Year
- ATOS N/A
- BLNK $2.17
- Revenue Next Year
- ATOS N/A
- BLNK $32.64
- P/E Ratio
- ATOS N/A
- BLNK N/A
- Revenue Growth
- ATOS N/A
- BLNK N/A
- 52 Week Low
- ATOS $0.55
- BLNK $0.63
- 52 Week High
- ATOS $1.81
- BLNK $3.75
- Technical
- Relative Strength Index (RSI)
- ATOS 58.85
- BLNK 36.04
- Support Level
- ATOS $0.59
- BLNK $0.65
- Resistance Level
- ATOS $0.67
- BLNK $0.71
- Average True Range (ATR)
- ATOS 0.06
- BLNK 0.07
- MACD
- ATOS 0.01
- BLNK -0.00
- Stochastic Oscillator
- ATOS 88.47
- BLNK 26.68
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.